NCT07183800 Trampoline-Induced Changes in Pelvic Structure and Continence
| NCT ID | NCT07183800 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Ottawa |
| Condition | Urinary Continence |
| Study Type | OBSERVATIONAL |
| Enrollment | 30 participants |
| Start Date | 2025-07-16 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30 participants in total. It began in 2025-07-16 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to evaluate whether a short bout of high-intensity trampoline jumping induces urinary leakage or measurable changes in pelvic floor morphology in active females aged 18-40 who do not report symptoms of urinary incontinence. The main questions it aims to answer are: Hypothesis 1: Does a single 10-minute trampoline protocol result in acute changes in pelvic floor structure, including bladder neck position, levator plate length, and/or posterior urethrovesical angle (PUVA)? Hypothesis 2: Do participants report any urinary leakage during the jumping protocol, despite being asymptomatic at baseline? Hypothesis 3: Do pelvic morphology changes recover within 30 minutes post-jumping, or do alterations persist? Researchers will perform within-subject comparisons at multiple time points (pre-jump, immediately post-jump, and 30 minutes post-jump) using transperineal ultrasound imaging to assess structural changes. Participants will: * Attend one laboratory visit * Complete baseline pelvic health questionnaires (ICIQ-UI Short Form and PFD Sentinel). * Undergo 2D transperineal ultrasound imaging in the standing position at rest, immediately post-jumping, and 30 minutes post-jumping. * Perform a 10-minute high-intensity jumping protocol on a mini-trampoline, while heart rate and perceived exertion are monitored. * Verbally report any urine leakage during jumping using standardized descriptors.
Eligibility Criteria
Inclusion Criteria: * Aged 18-40 * Engage in regular physical activity or sport * Do not experience frequent urinary leakage (no more than once per month during exercise, coughing, or sneezing) * Can complete a 10-minute jumping protocol Exclusion Criteria: * Currently pregnant or have been pregnant in the past 6 months * Have cardiac, pulmonary, metabolic, and/or neurological conditions * Have a lower body injury that limits your ability to jump * Have had a hysterectomy and/or incontinence surgery
Frequently Asked Questions
Who can join the NCT07183800 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 40 Years, studying Urinary Continence. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07183800 currently recruiting?
Yes, NCT07183800 is actively recruiting participants. Visit ClinicalTrials.gov or contact University of Ottawa to inquire about joining.
Where is the NCT07183800 trial being conducted?
This trial is being conducted at Ottawa, Canada.
Who is sponsoring the NCT07183800 clinical trial?
NCT07183800 is sponsored by University of Ottawa. The trial plans to enroll 30 participants.